Christa Burger

Title: Christa Burger: Innovator in Pharmaceutical Chemistry

Introduction

Christa Burger is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. Her work focuses on developing novel compounds and methods that have the potential to treat various diseases.

Latest Patents

Among her latest patents is the invention of benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonists. This invention provides novel substituted benzyl piperidine compounds that can be used for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis, or arthritis. Another notable patent involves enhancing the circulating half-life of antibody-based fusion proteins. This patent discloses methods and compositions that rely on altering the amino acid sequence of the junction region between the antibody moiety and the fused protein moiety. The resulting antibody-based fusion protein has a greater circulating half-life when administered to a mammal, making it particularly useful for reducing tumor size and metastasis.

Career Highlights

Christa has worked with notable companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. Her experience in these organizations has allowed her to develop and refine her innovative ideas in drug development.

Collaborations

Throughout her career, Christa has collaborated with esteemed colleagues, including Stephen D. Gillies and Kin-Ming Lo. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Christa Burger is a trailblazer in the field of pharmaceutical chemistry, with a focus on innovative solutions for treating serious health conditions. Her patents reflect her dedication to improving medical treatments and enhancing patient outcomes.